These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 25048787)

  • 1. Incorporating targeted agents into future therapy of chronic lymphocytic leukemia.
    Pallasch CP; Hallek M
    Semin Hematol; 2014 Jul; 51(3):235-48. PubMed ID: 25048787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel agents for the treatment of chronic lymphocytic leukemia.
    Abou-Nassar K; Brown JR
    Clin Adv Hematol Oncol; 2010 Dec; 8(12):886-95. PubMed ID: 21326166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies.
    Hallek M
    Hematology Am Soc Hematol Educ Program; 2013; 2013():138-50. PubMed ID: 24319175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bruton tyrosine kinase inhibition in chronic lymphocytic leukemia.
    Maddocks K; Jones JA
    Semin Oncol; 2016 Apr; 43(2):251-9. PubMed ID: 27040703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal transduction inhibitors in chronic lymphocytic leukemia.
    Ma S; Rosen ST
    Curr Opin Oncol; 2011 Nov; 23(6):601-8. PubMed ID: 21892084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signaling the end of chronic lymphocytic leukemia: new frontline treatment strategies.
    Hallek M
    Blood; 2013 Nov; 122(23):3723-34. PubMed ID: 24065239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody therapy alone and in combination with targeted drugs in chronic lymphocytic leukemia.
    Robak T; Blonski JZ; Robak P
    Semin Oncol; 2016 Apr; 43(2):280-90. PubMed ID: 27040707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted Agents.
    Maly J; Blachly JS
    Curr Hematol Malig Rep; 2016 Feb; 11(1):52-60. PubMed ID: 26893063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of Chronic Lymphocytic Leukemia in the Elderly.
    Barrientos JC
    Cancer Control; 2015 Oct; 22(4 Suppl):17-23. PubMed ID: 26618342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of chronic lymphocytic leukemia (CLL) in the era of B-cell receptor signal transduction inhibitors.
    Mato A; Jauhari S; Schuster SJ
    Am J Hematol; 2015 Jul; 90(7):657-64. PubMed ID: 25808792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy-free treatment of chronic lymphocytic leukemia?].
    Wendtner CM
    Dtsch Med Wochenschr; 2013 Oct; 138(41):2104-6. PubMed ID: 24085367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Targeted Therapies for Chronic Lymphocytic Leukemia in Elderly Patients: A Systematic Review.
    Farooqui AA; Ashraf A; Farooq TB; Anjum A; Rehman SU; Akbar A; Kanate A; Dean R; Ahmed MQ; Tariq MJ; Nabeel S; Faisal MS; Anwer F
    Clin Lymphoma Myeloma Leuk; 2020 Jul; 20(7):e414-e426. PubMed ID: 32291235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The B-cell receptor pathway: a critical component of healthy and malignant immune biology.
    Zhong Y; Byrd JC; Dubovsky JA
    Semin Hematol; 2014 Jul; 51(3):206-18. PubMed ID: 25048784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCR pathway inhibition as therapy for chronic lymphocytic leukemia and lymphoplasmacytic lymphoma.
    Wiestner A
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):125-34. PubMed ID: 25696845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The shrinking role of chemotherapy in the treatment of chronic lymphocytic leukemia.
    Jacobs RW; Awan FT; Leslie LA; Usmani SZ; Ghosh N
    Expert Rev Hematol; 2016 Dec; 9(12):1177-1187. PubMed ID: 27791448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Towards targeted therapy of chronic lymphocytic leukemia.
    Niemann CU; Jones J; Wiestner A
    Adv Exp Med Biol; 2013; 792():259-91. PubMed ID: 24014301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging immunological drugs for chronic lymphocytic leukemia.
    Robak P; Smolewski P; Robak T
    Expert Opin Emerg Drugs; 2015 Sep; 20(3):423-47. PubMed ID: 26153226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted Therapy in Chronic Lymphocytic Leukemia (CLL).
    Pettijohn EM; Ma S
    Curr Hematol Malig Rep; 2017 Feb; 12(1):20-28. PubMed ID: 28155013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond detectable minimal residual disease in chronic lymphocytic leukemia.
    Hillmen P
    Semin Oncol; 2006 Apr; 33(2 Suppl 5):S23-8. PubMed ID: 16720200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New oral small molecules in the treatment of chronic lymphocytic leukemia.
    Lamanna N
    Cancer; 2015 Jun; 121(12):1917-26. PubMed ID: 25690403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.